(New) Methods for Detection of Aspergillus fumigatus Resistance in Clinical Samples

Jeffrey D Jenks1, Birgit Spiess2, Dieter Buchheidt2

  • 1Department of Medicine, University of California San Diego, San Diego, CA 92103, USA.

Abstract

Insights

New molecular methods can now detect triazole resistance in Aspergillus fumigatus, addressing limitations of traditional culture methods. These advancements are crucial for managing invasive aspergillosis, especially in immunocompromised patients.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Molecular Diagnostics

Background:

  • Invasive aspergillosis incidence is rising, with increasing resistance of Aspergillus fumigatus to key triazole antifungals like voriconazole and isavuconazole.
  • Current culture-based methods for detecting triazole resistance are the gold standard but are slow and lack sensitivity.
  • There is a critical need for improved diagnostic methods to identify triazole resistance in Aspergillus.

Purpose of the Study:

  • To review and update on non-culture-based methods for detecting triazole resistance patterns in Aspergillus species.
  • To highlight the clinical and epidemiological relevance of novel diagnostic approaches.

Main Methods:

  • Development of molecular-based approaches, specifically real-time polymerase chain reaction (PCR).
  • Detection of mutations in the Cyp51A gene, a key indicator of triazole resistance.
  • Evaluation of these methods for identifying triazole-resistant Aspergillus fumigatus strains.

Main Results:

  • New real-time PCR assays can effectively detect mutations conferring triazole resistance in Aspergillus fumigatus.
  • These molecular methods demonstrate high sensitivity in identifying resistant strains in patients with invasive aspergillosis.
  • The assays can detect most common triazole-resistant Aspergillus fumigatus strains.

Conclusions:

  • Non-culture-based molecular methods offer a promising alternative to traditional culture techniques for Aspergillus triazole resistance detection.
  • These methods are particularly valuable in immunocompromised patients, such as those with hematological malignancies, where culture sensitivity is limited.
  • The clinical utility of these assays is influenced by regional variations in resistance rates.